Michel Hanss

1.2k total citations
40 papers, 767 citations indexed

About

Michel Hanss is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Internal Medicine. According to data from OpenAlex, Michel Hanss has authored 40 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 15 papers in Pulmonary and Respiratory Medicine and 12 papers in Internal Medicine. Recurrent topics in Michel Hanss's work include Blood properties and coagulation (14 papers), Venous Thromboembolism Diagnosis and Management (12 papers) and Platelet Disorders and Treatments (8 papers). Michel Hanss is often cited by papers focused on Blood properties and coagulation (14 papers), Venous Thromboembolism Diagnosis and Management (12 papers) and Platelet Disorders and Treatments (8 papers). Michel Hanss collaborates with scholars based in France, Belgium and United States. Michel Hanss's co-authors include Désiré Collen, Fabrice Biot, M Dechavanne, Philippe de Mazancourt, Patrick Ffrench, Laurent Derex, P Trouillas, A. Aouifi, Olivier Bastien and Jean-Jacques Lehot and has published in prestigious journals such as Annals of the New York Academy of Sciences, PLoS Pathogens and The Annals of Thoracic Surgery.

In The Last Decade

Michel Hanss

39 papers receiving 726 citations

Peers

Michel Hanss
Kerrie A. Smith United Kingdom
E. Cutz Canada
Yayan Bi China
Kerstin Jurk Germany
Irving B. Mink United States
Michel Hanss
Citations per year, relative to Michel Hanss Michel Hanss (= 1×) peers Tamara Brunelli

Countries citing papers authored by Michel Hanss

Since Specialization
Citations

This map shows the geographic impact of Michel Hanss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Hanss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Hanss more than expected).

Fields of papers citing papers by Michel Hanss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Hanss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Hanss. The network helps show where Michel Hanss may publish in the future.

Co-authorship network of co-authors of Michel Hanss

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Hanss. A scholar is included among the top collaborators of Michel Hanss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Hanss. Michel Hanss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanss, Michel, et al.. (2024). In vitro effect of hydroxyethyl starch on COVID-19 patients–associated hypofibrinolytic state. Research and Practice in Thrombosis and Haemostasis. 8(2). 102382–102382. 1 indexed citations
2.
Brennan, Stephen O., Howard Potter, & Michel Hanss. (2016). Bisalbuminaemia due to novel mutation at a critical residue involved in recycling; Albumin Lyon (510His → Arg). Clinical Biochemistry. 49(7-8). 544–547. 1 indexed citations
3.
Berthiller, Julien, et al.. (2015). Early fibrinogen degradation coagulopathy: A predictive factor of parenchymal hematomas in cerebral rt-PA thrombolysis. Journal of the Neurological Sciences. 351(1-2). 109–114. 23 indexed citations
4.
Farghali, Ahmed A., Michel Hanss, Julien Berthiller, et al.. (2014). Fibrinogen and von Willebrand Factor and Susceptibility Vessel Sign on T2*-Weighted Gradient Echo Imaging. European Neurology. 72(5-6). 375–377. 1 indexed citations
5.
Berthiller, Julien, et al.. (2014). Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome. Journal of the Neurological Sciences. 349(1-2). 77–83. 15 indexed citations
6.
Berri, Fatma, Guus F. Rimmelzwaan, Michel Hanss, et al.. (2013). Plasminogen Controls Inflammation and Pathogenesis of Influenza Virus Infections via Fibrinolysis. PLoS Pathogens. 9(3). e1003229–e1003229. 67 indexed citations
8.
Dargaud, Yesim, Philippe de Mazancourt, Lucia Rugeri, et al.. (2008). An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapy. Blood Coagulation & Fibrinolysis. 19(5). 447–452. 9 indexed citations
9.
Gillet, Jean-Luc, et al.. (2007). Valeur des D-dimères lors des thromboses veineuses superficielles des membres inférieurs. Journal des Maladies Vasculaires. 32(2). 90–95. 15 indexed citations
10.
Hanss, Michel, Patrick Ffrench, Jean‐François Mornex, et al.. (2003). Two novel fibrinogen variants found in patients with pulmonary embolism and their families. Journal of Thrombosis and Haemostasis. 1(6). 1251–1257. 16 indexed citations
11.
Hanss, Michel, et al.. (2003). A splicing donor site point mutation in intron 6 of the plasmin inhibitor (α2 antiplasmin) gene with heterozygous deficiency and a bleeding tendency. Blood Coagulation & Fibrinolysis. 14(1). 107–111. 6 indexed citations
13.
Aouifi, A., Pascale Blanc, Vincent Piriou, et al.. (2001). Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia. The Annals of Thoracic Surgery. 71(2). 678–683. 48 indexed citations
14.
Hanss, Michel & Fabrice Biot. (2001). A Database for Human Fibrinogen Variants. Annals of the New York Academy of Sciences. 936(1). 89–90. 130 indexed citations
15.
Hanss, Michel, B. Coppéré, Évelyne Gineyts, et al.. (1994). Increased plasma free gamma carboxyglutamic acid levels during deep vein thrombosis and intravascular disseminated coagulation. Thrombosis Research. 73(3-4). 185–192. 4 indexed citations
16.
Gaucher, Christine, Michel Hanss, M Dechavanne, & Claudine Mazurier. (1993). Substitution of cysteine for phenylalanine 751 in mature von Willebrand factor is a novel candidate mutation in a family with type IIA von Willebrand disease. British Journal of Haematology. 83(1). 94–99. 12 indexed citations
17.
Hanss, Michel, et al.. (1991). Des‐gamma‐carboxyprothrombin detection by immunoblotting after polyacrylamide gel affinoelectrophoresis in human plasmas. Electrophoresis. 12(4). 294–297. 7 indexed citations
18.
Hanss, Michel, et al.. (1990). Increased Plasma Tissue-Type Plasminogen Activator Levels in Patients with Chronic Thrombocytopenia. Pathophysiology of Haemostasis and Thrombosis. 20(6). 341–346. 1 indexed citations
19.
Croset, Martine, Evelyne Véricel, Michel Rigaud, et al.. (1990). Functions and tocopherol content of blood platelets from elderly people after low intake of purified eicosapentaenoic acid. Thrombosis Research. 57(1). 1–12. 40 indexed citations
20.
Hanss, Michel & M Dechavanne. (1988). 48740 RP, An antagonist of PAF, does not affect human plasma fibrinolysis before and after venous occlusion. Thrombosis Research. 49(1). 129–132. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026